Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04783415
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-18
First Post:
2021-02-25
Brief Title:
Acalabrutinib Umbralisib and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mantle Cell Lymphoma |
Keywords: